Tool: Third-Party Risk Management Guide for Medical Labs
Key cybersecurity points to address when working with a third party that has access to protected health information
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Key cybersecurity points to address when working with a third party that has access to protected health information
The ALZpath DX assay is less invasive than other diagnostic tests, and may give patients diagnosed with Alzheimer’s more time to plan
The impending legislation that may determine Medicare lab fees from 2025 onward
Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.
Formulating queries that are compliant, informative, and effective—even in tricky situations.
Program outlined in a recently introduced bill would test AI’s effectiveness in detecting suspect payments for diagnostic tests and DME.
How clinical laboratory professionals can advocate for legislative and regulatory improvements
Joyce Gresko, partner at Alston & Bird, discusses the latest on PAMA and what will likely need to happen for SALSA to pass in 2024.
Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
Both companies have made recent moves to diversify further.